PB2284: PROTECTION OF PATIENTS WITH HEMATOLOGIC MALIGNANCY FROM SEVERE INFECTION DURING PANDEMIA: ESTONIAN TWO CENTRES EXPERIENCE

por Vaide, I., Aabrams, V., Laane, E.
Publicado 2022

P1705: PATIENT-REPORTED OUTCOMES IN MYELOPROLIFERATIVE NEOPLASMS IN CLINICAL TRIALS: A SYSTEMATIC REVIEW

por Oliva, E. N., Salek, S., Laane, E., Andreas, M., Csenar, M., Skoetz, N., Ionova, T.
Publicado 2022

Glucocorticoid-induced cell death is mediated through reduced glucose metabolism in lymphoid leukemia cells

por Buentke, E, Nordström, A, Lin, H, Björklund, A-C, Laane, E, Harada, M, Lu, L, Tegnebratt, T, Stone-Elander, S, Heyman, M, Söderhäll, S, Porwit, A, Östenson, C-G, Shoshan, M, Tamm, K Pokrovskaja, Grandér, D
Publicado 2011

P1724: QUALITY OF LIFE AND UNMET NEEDS AMONG PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASM PATIENTS: RESULTS OF THE NATIONWIDE SURVEY

por Ionova, T., Andreevskaya, E., Babich, E., Bulieva, N., Vinogradova, O., Volodicheva, E., Voloshin, S., Glonina, N., Dubov, S., Esefieva, N., Zinina, E., Ivanova, M., Klitochenko, T., Kopylova, A., Kulagin, A., Kuchma, G., Li, O., Lomaia, E., Melikyan, A., Melnichenko, V., Menshakova, S., Mitina, T., Morozova, E., Osipova, E., Ochirova, O., Polyakov, A., Pospelova, T., Proydakov, A., Rukavitsyn, O., Safuanova, G., Subortseva, I., Fominykh, M., Frolova, M., Shelekhova, T., Sherstnev, D., Shneyder, T., Shuvaev, V., Laane, E., Oliva, E., Salek, S., Nikitina, T.
Publicado 2022